Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KOD Kodiak Sciences > Main Composition
KOD Kodiak Sciences
7.290
-0.090-1.22%
All
YOY
Do not show
Business

No Data

Region

No Data

Company Overview More
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
CEO: Dr. Victor Perlroth, M.D.
Market: NASDAQ
Listing Date: 10/04/2018
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist